Chronic lymphocytic leukemia (CLL) is characterized by the progressive expansion of B lymphocytes CD5+/CD23+ in peripheral blood, lymph-nodes, and bone marrow. Here, FCER2 is linked to B-cell chronic lymphocytic leukemia.